Amgen Increase Decrease In Accrued Income Taxes Payable increased by 119.5% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.7%, from $104.00M to $71.00M.
An increase indicates that tax liabilities are accruing, which preserves cash in the short term.
This represents the change in the amount of income tax the company owes to government authorities for the current period...
Standard across all tax-paying entities; fluctuates based on tax filing schedules.
other_increase_decrease_in_accrued_income_taxes_payable| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$982.00M | -$135.00M | $318.00M | -$1.00B | -$155.00M | $443.00M | $28.00M | $527.00M | -$2.03B | $223.00M | -$1.53B | $104.00M | -$2.42B | -$365.00M | $71.00M |
| QoQ Change | — | +86.3% | +335.6% | -415.4% | +84.5% | +385.8% | -93.7% | >999% | -485.0% | +111.0% | -787.9% | +106.8% | <-999% | +84.9% | +119.5% |
| YoY Change | — | — | — | -2.1% | -14.8% | +39.3% | +102.8% | — | <-999% | -49.7% | <-999% | -53.4% | -57.6% | — | -31.7% |